Porton Down, UK, 28 February 2007: A leading neurology journal, The European Journal of Neurology, today reports a study showing that Sativex significantly reduces intractable spasticity (spasms and stiffness) in people with Multiple Sclerosis (MS). The publication of these data follows the previous announcement of preliminary results of this 189 patient study, which forms part of the regulatory filing for Sativex for MS spasticity submitted in September 2006 in selected European countries.
